SCHEMBL2159141

SCHEMBL2159141

CC(C)C(Nc1ccccc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.59
▸ GAA P10253 2/20 0.59
▸ HPGD P15428 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ TDP1 Q9NUW8 2/20 0.52
▸ ALDH1A1 P00352 4/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ ALOX12 P18054 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ CTSL P07711 1/20 0.49
▸ CTSB P07858 1/20 0.49
▸ CTSK P43235 1/20 0.49
▸ MMP2 P08253 3/20 0.47
▸ MMP3 P08254 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8745550 1.00 LMNA (0.59) LMNAGAAHPGDSMN1; SMN2TDP1
SCHEMBL2159137 1.00 LMNA (0.59) LMNAGAAHPGDSMN1; SMN2TDP1
Hydrochloric Acid SCHEMBL11195536 0.98 LMNA (0.57) LMNAGAAHPGDSMN1; SMN2TDP1
Hydrochloric Acid SCHEMBL11195541 0.98 LMNA (0.57) LMNAGAAHPGDSMN1; SMN2TDP1
SCHEMBL11194066 0.86 TDP1 (0.50) LMNAGAAHPGDSMN1; SMN2TDP1
Benzene SCHEMBL27670933 0.86 TDP1 (0.50) LMNAGAAHPGDSMN1; SMN2TDP1
SCHEMBL11201043 0.84 MAPT (0.49) LMNAGAAHPGDSMN1; SMN2TDP1
SCHEMBL5674194 0.84 TDP1 (0.48) LMNAGAAHPGDSMN1; SMN2TDP1
SCHEMBL11193286 0.84 MMP9 (0.51) LMNAGAAHPGDSMN1; SMN2TDP1
SCHEMBL11196494 0.84 ADAMTS4 (0.51) LMNAGAAHPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3326715-B1 OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE CE PHARM CO LTD (CN) 2021-09-15 — — EP disclosed
US-20180207628-A1 OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2018-07-26 — — US disclosed
EP-3326715-A1 OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) 2018-05-30 — — EP disclosed
EP-2471774-B1 Piperidinyl derivatives as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO (US) 2016-08-24 — — EP disclosed
EP-2471774-A1 Piperidinyl derivatives as modulators of chemokine receptor activity Bristol-Myers Squibb Company (US) 2012-07-04 — — EP disclosed
US-20110245226-A1 PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY 2011-10-06 — — US disclosed
US-7985861-B2 Piperidinyl derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2011-07-26 — — US disclosed
CN-101600691-A Acyclic derivatives as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO (US) 2009-12-09 — — CN disclosed
US-20090298833-A1 PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY 2009-12-03 — — US disclosed
US-7601844-B2 Piperidinyl derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-13 — — US disclosed
US-5378579-A Unsaturated monomer, unsaturated carboxylamine free radical initiator, absorber, film-forming polymer NIPPON PAINT CO., LTD. (JP) 1995-01-03 — — US disclosed
EP-0581311-A2 Alkali developable photosensitive resin composition Nippon Paint Co., Ltd. (JP) 1994-02-02 — — EP disclosed
EP-0522568-A1 Photopolymerizable composition and photosensitive lithographic printing plate Nippon Paint Co., Ltd. (JP) 1993-01-13 — — EP disclosed
US-4517130-A Substituted amino acid process ZOECON CORPORATION (US) 1985-05-14 — — US disclosed
US-4411912-A Insecticidal isovaleric acid esters ZOECON CORPORATION (US) 1983-10-25 — — US disclosed
US-4276230-A Cyano-3-phenoxybenzyl N-1-(1-naphthyl) ethylcarbamate ZOECON CORPORATION (US) 1981-06-30 — — US disclosed
US-4252724-A Novel compositions ZOECON CORPORATION (US) 1981-02-24 — — US disclosed
US-4243819-A Substituted amino acids ZOECON CORPORATION (US) 1981-01-06 — — US disclosed
US-4231953-A Fluoro substituted aryl esters and thiolesters of amino acids ZOECON CORPORATION (US) 1980-11-04 — — US disclosed
US-4226872-A Pyridyl esters of α-substituted amino acids ZOECON CORPORATION (US) 1980-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298833-A1 PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY CCR1, CCR2, CCR3 LMNA 4849/4885GAA 4142/4885HPGD 1384/4885
US-20110245226-A1 PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY CCR1, CCR2, CCR3 LMNA 4849/4885GAA 4142/4885HPGD 1384/4885
US-20180207628-A1 OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE AOC2, AOC1, AOC3 LMNA 4691/4885GAA 1636/4885HPGD 1526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback